mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |